118 related articles for article (PubMed ID: 12566120)
1. Genetic basis for chamber-specific ventricular phenotypes in the rat infarct model.
Chugh SS; Whitesel S; Turner M; Roberts CT; Nagalla SR
Cardiovasc Res; 2003 Feb; 57(2):477-85. PubMed ID: 12566120
[TBL] [Abstract][Full Text] [Related]
2. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
3. Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction.
Gidh-Jain M; Huang B; Jain P; Gick G; El-Sherif N
J Mol Cell Cardiol; 1998 Mar; 30(3):627-37. PubMed ID: 9515038
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of voltage-gated K+ channel genes in left ventricular remodeled myocardium after experimental myocardial infarction.
Gidh-Jain M; Huang B; Jain P; el-Sherif N
Circ Res; 1996 Oct; 79(4):669-75. PubMed ID: 8831490
[TBL] [Abstract][Full Text] [Related]
5. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
6. Cardiac and noncardiac atrial natriuretic factor (ANF) biosynthesis and storage and plasma ANF in the rat model of chronic ventricular dysfunction.
Bilder GE; Sweet CS; Emmert SE; Schofield TL; Medina R; Stabilito II; Friedman PA
Endocrinology; 1989 Mar; 124(3):1515-21. PubMed ID: 2521823
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular remodeling in swine after myocardial infarction: a transcriptional genomics approach.
Kuster DW; Merkus D; Kremer A; van Ijcken WF; de Beer VJ; Verhoeven AJ; Duncker DJ
Basic Res Cardiol; 2011 Nov; 106(6):1269-81. PubMed ID: 22057716
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
[TBL] [Abstract][Full Text] [Related]
9. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
10. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.
Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
Chest; 2005 Sep; 128(3):1812-21. PubMed ID: 16162791
[TBL] [Abstract][Full Text] [Related]
11. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling implies mitochondrial dysfunction in tachycardia-induced heart failure.
Birner C; Dietl A; Deutzmann R; Schröder J; Schmid P; Jungbauer C; Resch M; Endemann D; Stark K; Riegger G; Luchner A
J Card Fail; 2012 Aug; 18(8):660-73. PubMed ID: 22858083
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
14. The effect of allogeneic cardiac stem cells in left ventricular geometry and function in a rat model of myocardial infarction.
Weng Y; Zhang X; Liu A; Cai W; Li F; Wang T
Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 29171187
[TBL] [Abstract][Full Text] [Related]
15. [Alterations in aortic vasomotor function in rats with chronic heart failure and its mechanism].
Zhang HL; Zhao M; He X; Jiang HK; Yu XJ; Ma X; Zang WJ
Sheng Li Xue Bao; 2010 Aug; 62(4):317-24. PubMed ID: 20717632
[TBL] [Abstract][Full Text] [Related]
16. Single measurement of troponin T for early prediction of infarct size, congestive heart failure, and pulmonary hypertension in an animal model of myocardial infarction.
Jiang BH; Nguyen QT; Tardif JC; Shi Y; Dupuis J
Cardiovasc Pathol; 2011; 20(3):e85-9. PubMed ID: 20537565
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
Tao ZW; Huang YW; Xia Q; Xu QW
Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
[TBL] [Abstract][Full Text] [Related]
18. Defining the molecular signatures of human right heart failure.
Williams JL; Cavus O; Loccoh EC; Adelman S; Daugherty JC; Smith SA; Canan B; Janssen PML; Koenig S; Kline CF; Mohler PJ; Bradley EA
Life Sci; 2018 Mar; 196():118-126. PubMed ID: 29366750
[TBL] [Abstract][Full Text] [Related]
19. Effects of levosimendan on cardiac gene expression profile and post-infarct cardiac remodelling in diabetic Goto-Kakizaki rats.
Vahtola E; Storvik M; Louhelainen M; Merasto S; Lakkisto P; Lakkisto J; Tikkanen I; Kaheinen P; Levijoki J; Mervaala E
Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):387-97. PubMed ID: 21699655
[TBL] [Abstract][Full Text] [Related]
20. Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome.
Liu S; Kompa AR; Kumfu S; Nishijima F; Kelly DJ; Krum H; Wang BH
Int J Cardiol; 2013 Oct; 168(3):1866-80. PubMed ID: 23347614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
